All In MedTech

FDA Clearance Tracker · P010015-S107

INSYNC CRT-P/INSYNC III CRT-P

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 13, 2011 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 13, 2011

Approved

Time to decision

129 days

Received Jan 4, 2011. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P010015-S107
Device name
INSYNC CRT-P/INSYNC III CRT-P
Applicant location
Mounds View, MN
Received
Jan 4, 2011
Decided
May 13, 2011
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P010015

Device type

Device class
Class III

Every decision under product code OJX

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE MEDTRONIC MODEL 9986 DESKTOP/ BOSS VERSION 2.4 FOR USE ON THE MEDTRONIC MODEL 2090 CARELINK PROGRAMMER.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.